Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

This Stock Has Been Immune to the Sell-Off

When you're going through a sell-off like the one that's been beating us up in recent days, you need to keep an eye out for stocks that appear to be dodging the punches.

And that's just the situation we seem to have with Enanta Pharmaceuticals Inc. (NasdaqGS: ENTA), a biotech stock that has already advanced nearly 15% since we recommended it on Jan. 2.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK